Pharm Delve Cognizance
Aug 16, 2016
To download the pdf version of the Newsletter: Click the following
DelveInsight Newsletter
Downloads
Click Here To Get the Article in PDF
Recent Articles
- Chimeric Antigen Receptor T-cell Therapy Landscape
- PTC Therapeutics’ Gene Therapy Upstaza; Sanofi and Regeneron’s Dupixent; Bayer CAR-T Collaboratio...
- Roche’s Phase 2 data; Celgene and Bluebird’s CAR-T therapy; Regeneron/Sanofi gets results; Allerg...
- AKT Inhibitors: A potential Cancer Immunotherapy Target
- Novartis’ Canakinumab for NSCLC; Novartis’s Zolgensma Updates; Trodelvy Prospects in New Breast C...
Downloads
Article in PDF
Recent Articles
- PTC Therapeutics’ Gene Therapy Upstaza; Sanofi and Regeneron’s Dupixent; Bayer CAR-T Collaboratio...
- CAR-T Phase I trials; ContraVir Announces; Merck acquired; Excision BioTherapeutics bags $10M
- Collaboration provides new insight into cancer treatment
- Snippet
- Why should every company working on CAR-T therapy attend CAR TCR Summit Europe?
